Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
1 Year Return
+41.49%
3 Year Return
5 Year Return
10 Year Return
AUM
$75.2B
AUM Growth
+$9.1B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
4,018
New
Increased
Reduced
Closed

Top Buys

1 +$1B
2 +$721M
3
AAPL icon
Apple
AAPL
+$468M
4
UNH icon
UnitedHealth
UNH
+$422M
5
GEV icon
GE Vernova
GEV
+$376M

Sector Composition

1 Technology 19.67%
2 Healthcare 15.79%
3 Consumer Discretionary 12.38%
4 Financials 11.51%
5 Industrials 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRT icon
3176
Marti Technologies
MRT
$182M
$195K ﹤0.01%
64,500
+45,412
TBI
3177
Trueblue
TBI
$166M
$194K ﹤0.01%
+29,900
IOBT icon
3178
IO Biotech
IOBT
$36.4M
$194K ﹤0.01%
139,300
+12,900
RBKB icon
3179
Rhinebeck Bancorp
RBKB
$126M
$194K ﹤0.01%
+16,500
SGRP icon
3180
SPAR Group
SGRP
$25.6M
$193K ﹤0.01%
201,300
-6,285
CABA icon
3181
Cabaletta Bio
CABA
$212M
$192K ﹤0.01%
126,100
+115,200
NERV icon
3182
Minerva Neurosciences
NERV
$16.4M
$191K ﹤0.01%
111,000
-3,097
APLS icon
3183
Apellis Pharmaceuticals
APLS
$3.17B
$190K ﹤0.01%
+10,988
ENLV icon
3184
Enlivex Therapeutics
ENLV
$27.9M
$189K ﹤0.01%
168,392
-12,897
LODE icon
3185
Comstock
LODE
$168M
$188K ﹤0.01%
49,508
-15,300
COCP icon
3186
Cocrystal Pharma
COCP
$15M
$186K ﹤0.01%
125,028
-600
BRLT icon
3187
Brilliant Earth
BRLT
$31.4M
$185K ﹤0.01%
134,600
+1,800
JBS
3188
JBS N.V.
JBS
$14B
$181K ﹤0.01%
+12,538
FGNX
3189
FG Nexus Inc
FGNX
$6.64M
$180K ﹤0.01%
11,231
-300
BETR icon
3190
Better Home & Finance Holding
BETR
$870M
$179K ﹤0.01%
+14,452
SPWH icon
3191
Sportsman's Warehouse
SPWH
$107M
$179K ﹤0.01%
51,800
-297,700
NSTS icon
3192
NSTS Bancorp
NSTS
$59.2M
$178K ﹤0.01%
14,400
RAPP
3193
Rapport Therapeutics
RAPP
$1.22B
$177K ﹤0.01%
+15,600
ZENV icon
3194
Zenvia
ZENV
$72.9M
$177K ﹤0.01%
118,201
-15,000
MGX icon
3195
Metagenomi
MGX
$107M
$176K ﹤0.01%
119,000
+19,400
CELC icon
3196
Celcuity
CELC
$1.95B
$175K ﹤0.01%
+13,100
QSI icon
3197
Quantum-Si Incorporated
QSI
$338M
$175K ﹤0.01%
89,200
-782,556
DARE icon
3198
Dare Bioscience
DARE
$28.6M
$172K ﹤0.01%
71,795
+1,200
AHG
3199
Akso Health Group
AHG
$879M
$170K ﹤0.01%
130,798
-14,400
OTLK icon
3200
Outlook Therapeutics
OTLK
$53.3M
$170K ﹤0.01%
+106,068